Alterity Therapeutics Limited American Depositary Shares (ATHE)
Stock · NASDAQ · Health Care
$4.51as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$4.5
Industry
Biotechnology: Pharmaceutical Preparations
About ATHE
Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to tr…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 9
- Website
- alteritytherapeutics.com/
Fundamentals
- 1-day range
- $4.46$4.83
- Market cap
- $80.78M
- P/E (trailing)
- —
- P/E (forward)
- -4.56
- EPS (trailing)
- $-0.08
- Dividend yield
- —
- Beta
- 1.19
- Avg. volume
- 44.5K
52-week range
$0.01$0.785
Next earnings: August 25, 2015 · EPS estimate $-5.58
Forecasts
4 analyst ratings
Buy 80%
Hold 20%
Sell 0%
1-year price forecast
High
$16
+254.8%
Median
$13.5
+199.3%
Low
$10
+121.7%
Alterity Therapeutics Limited American Depositary Shares Competitors
Chosen by industry and closest market cap.
- ATHEAlterity Therapeutics Limited American Depositary Shares$4.51▼ 1.10%Market cap $80.78MP/E —$0.01$0.785
- TELOTelomir Pharmaceuticals Inc. Common Stock$1.14▼ 4.20%Market cap $80.47MP/E —$0.8884$2.09
- MAIAMAIA Biotechnology Inc. Common Stock$1.33▼ 3.99%Market cap $80.26MP/E —$0.87$3.19
- NMADNomad Power Solutions Inc. Common Stock$4.33▼ 2.04%Market cap $81.57MP/E —$3.12$7.7
- LFVNLifevantage Corporation Common Stock (Delaware)$6.6▲ 2.33%Market cap $83.01MP/E 14.23$3.9$14.28
- ACETAdicet Bio Inc. Common Stock$9.05▲ 0.44%Market cap $86.38MP/E —$6.01$17.44
- GANXGain Therapeutics Inc. Common Stock$1.78▼ 3.78%Market cap $74.64MP/E —$1.53$4.34
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ATHE Alterity Therapeutics Limited American Depositary Shares | $80.78M | — | $4.51 | ▼ 1.10% | $0.01$0.785 |
| TELO Telomir Pharmaceuticals Inc. Common Stock | $80.47M | — | $1.14 | ▼ 4.20% | $0.8884$2.09 |
| MAIA MAIA Biotechnology Inc. Common Stock | $80.26M | — | $1.33 | ▼ 3.99% | $0.87$3.19 |
| NMAD Nomad Power Solutions Inc. Common Stock | $81.57M | — | $4.33 | ▼ 2.04% | $3.12$7.7 |
| LFVN Lifevantage Corporation Common Stock (Delaware) | $83.01M | 14.23 | $6.6 | ▲ 2.33% | $3.9$14.28 |
| ACET Adicet Bio Inc. Common Stock | $86.38M | — | $9.05 | ▲ 0.44% | $6.01$17.44 |
| GANX Gain Therapeutics Inc. Common Stock | $74.64M | — | $1.78 | ▼ 3.78% | $1.53$4.34 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Alterity Therapeutics Secures Key US Patent for Lead Assetbenzinga · 8/12/2026
- Alterity Therapeutics Secures Key US Patent for Lead AssetBenzinga · 8/12/2026
- Craig-Hallum Initiates Coverage On Alterity Therapeutics with Buy Rating, Announces Price Target of $12Benzinga · 8/11/2026
Insider Activity
Insider Actions →Acquired
3.00M
Disposed
0
- Babarczy Julian Michael · June 15, 2026 · Grant2.00M
- Gozlan Lawrence Bernard · June 15, 2026 · Grant1.00M
Institutional Ownership
March 31, 2026
- Total shares held
- 320.8K
- Total value held
- $1.11M
- Institutional holders
- 15
Top holders this quarter
- Unknown139.3K
- Unknown58.5K
- Unknown58.4K
- Unknown32.0K
- Unknown20.1K
- Unknown6.8K
- Unknown2.0K
- Unknown1.9K
- Unknown1.9K
- Unknown68
See the full, filterable feed with live charts on the MarketWall dashboard.